How Much Does Zepbound Cost?
The list price for Zepbound (tirzepatide) is $1,059.87 for a 28-day supply of one injector pen [1]. This price applies to all available dosage strengths [1].
What Insurance Coverage is Available for Zepbound?
Commercial insurance coverage for Zepbound varies. Many insurance plans do not cover Zepbound, and patients may face high out-of-pocket costs if their plan does not include coverage [2]. Eli Lilly, the manufacturer of Zepbound, offers a savings card program for eligible commercially insured patients. This program can reduce the monthly cost to as low as $550 for a 12-month supply [2].
How Does Zepbound's Price Compare to Other Weight-Loss Medications?
The price of Zepbound is comparable to other GLP-1 receptor agonists used for weight management, such as Wegovy (semaglutide) [3]. For example, Wegovy has a list price of approximately $1,300 per month [3]. However, actual costs for patients can differ significantly based on insurance coverage and available discount programs.
What Factors Influence the Price of Zepbound?
The pricing of Zepbound, like other specialty medications, is influenced by several factors. These include the drug's research and development costs, manufacturing expenses, clinical trial data demonstrating efficacy and safety, and the perceived market value for treating obesity [4].
When Will Zepbound's Patent Expiration Be Relevant?
Information regarding the specific patent expiration dates for Zepbound is publicly available through resources like DrugPatentWatch.com [5]. Understanding patent timelines is crucial for predicting when generic or biosimilar versions of the medication might become available, potentially impacting future pricing and accessibility.